Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Claritev Corporation (CTEV : NYSE)

• Company Description    Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. Number of Employees: 3,000

• Price / Volume Information    Yesterday's Closing Price: $13.47 Daily Weekly Monthly 20 Day Moving Average: 276,911 shares Shares Outstanding: 16.51 (millions) Market Capitalization: $222.38 (millions) Beta: 0.61 52 Week High: $74.00 52 Week Low: $12.04 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -50.40% -49.97% 12 Week -60.32% -60.37% Year To Date -68.49% -68.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7900 TYSONS ONE PLACE SUITE 400 - MCLEAN,VA 22102 USA ph: 212-780-2000 fax: - investor@multiplan.com http://www.claritev.com

• General Corporate Information    Officers Travis S. Dalton - Chief Executive Officer Douglas M. Garis - Executive Vice President and Chief Financial Offic Brock Albinson - Senior Vice President and Chief Accounting Officer Richard A. Clarke - Director Anthony Colaluca, Jr. - Director Peer Information Claritev Corporation (HLIS) Claritev Corporation (AZTA) Claritev Corporation (APYI) Claritev Corporation (RNVA) Claritev Corporation (HMSY) Claritev Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 62548M209 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 16.51 Most Recent Split Date: 9.00 (0.03:1) Beta: 0.61 Market Capitalization: $222.38 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-3.81 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-14.44 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 0.87 Price / Sales: 0.23 EPS Growth vs. Year Ago Period: 5.06% vs. Previous Quarter: -19.90% Sales Growth vs. Year Ago Period: 6.21% vs. Previous Quarter: 0.24% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - -245.89 ROA 12/31/25 - -3.96 09/30/25 - -3.96 06/30/25 - -3.18 Current Ratio 12/31/25 - 0.86 09/30/25 - 1.21 06/30/25 - 0.98 Quick Ratio 12/31/25 - 0.86 09/30/25 - 1.21 06/30/25 - 0.98 Operating Margin 12/31/25 - -20.53 09/30/25 - -21.14 06/30/25 - -17.51 Net Margin 12/31/25 - -29.45 09/30/25 - -35.93 06/30/25 - -70.91 Pre-Tax Margin 12/31/25 - -38.64 09/30/25 - -47.56 06/30/25 - -83.12 Book Value 12/31/25 - -10.13 09/30/25 - -6.17 06/30/25 - -2.42 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©